Tranexamic acid in subarachnoid hemorrhage
Completed
Phase N/A ResultsSummary of Purpose
To compare the effects of intravenous tranexamic acid with placebo in patients with subarachnoid hemorrhage.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 20 April 2001.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
Double-blind, randomized, placebo-controlled trial of 64 patients.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 64
- Max Time from Onset: 72 Hours
- Follow Up: 21 Days
Principal Investigator
-
Markku Kaste, M.D.
Department of Neurology, University of Helsinki, SF-00290 Helsinki 29, Finland
Locations
- Finland
